136 related articles for article (PubMed ID: 24371790)
1. Haemoglobinopathia Ypsilanti - A rare, but important differential diagnosis to polycythaemia vera.
Nygaard M; Petersen J; Bjerrum OW
Leuk Res Rep; 2013; 2(2):86-8. PubMed ID: 24371790
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytosis: genes and pathways involved in disease development.
Gašperšič J; Kristan A; Kunej T; Zupan IP; Debeljak N
Blood Transfus; 2021 Nov; 19(6):518-532. PubMed ID: 33370224
[TBL] [Abstract][Full Text] [Related]
3. [Acquired mutation of JAK2 tyrosine kinase and polycythaemia vera].
Pargade V; Darnige L; Gaussem P
Ann Biol Clin (Paris); 2006; 64(1):3-9. PubMed ID: 16420986
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of diagnostic approach to erythrocytosis of different genesis].
Ter Arkh; 2012; 84(4):29-35. PubMed ID: 22774487
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic hepatectomy in a patient with uncontrolled polycythaemia vera.
Riekki TR; Ling E; Cordovani D
Anaesth Rep; 2019; 7(2):92-95. PubMed ID: 32051960
[TBL] [Abstract][Full Text] [Related]
6. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
Campbell PJ; Scott LM; Buck G; Wheatley K; East CL; Marsden JT; Duffy A; Boyd EM; Bench AJ; Scott MA; Vassiliou GS; Milligan DW; Smith SR; Erber WN; Bareford D; Wilkins BS; Reilly JT; Harrison CN; Green AR; ; ;
Lancet; 2005 Dec; 366(9501):1945-53. PubMed ID: 16325696
[TBL] [Abstract][Full Text] [Related]
7. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
[TBL] [Abstract][Full Text] [Related]
8. Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis.
Rumi E; Passamonti F; Pagano L; Ammirabile M; Arcaini L; Elena C; Flagiello A; Tedesco R; Vercellati C; Marcello AP; Pietra D; Moratti R; Cazzola M; Lazzarino M
J Intern Med; 2009 Feb; 265(2):266-74. PubMed ID: 18793248
[TBL] [Abstract][Full Text] [Related]
9. High frequency of JAK2 exon 12 mutations in Korean patients with polycythaemia vera: novel mutations and clinical significance.
Park CH; Lee KO; Jang JH; Jung CW; Kim JW; Kim SH; Kim HJ
J Clin Pathol; 2016 Aug; 69(8):737-41. PubMed ID: 27198504
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytic colony formation in polycythaemia vera and secondary erythrocytosis.
Juvonen E; Partanen S; Ikkala E; Ruutu T
Br J Haematol; 1988 Aug; 69(4):441-4. PubMed ID: 3408680
[TBL] [Abstract][Full Text] [Related]
11. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.
Johansson PL; Safai-Kutti S; Kutti J
Br J Haematol; 2005 Jun; 129(5):701-5. PubMed ID: 15916693
[TBL] [Abstract][Full Text] [Related]
12. Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations.
Ibrahim IK; Hassan R; Ali EW; Omer A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):41-44. PubMed ID: 30677867
[TBL] [Abstract][Full Text] [Related]
13. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.
James C; Ugo V; Le Couédic JP; Staerk J; Delhommeau F; Lacout C; Garçon L; Raslova H; Berger R; Bennaceur-Griscelli A; Villeval JL; Constantinescu SN; Casadevall N; Vainchenker W
Nature; 2005 Apr; 434(7037):1144-8. PubMed ID: 15793561
[TBL] [Abstract][Full Text] [Related]
14. Polycythaemia Vera JAK 2 Mutation in a Patient with Underlying Chronic Obstructive Pulmonary Disease at a Primary Care Setting.
Mahmud R; Ariffin F; Shanmuganathan P
Korean J Fam Med; 2020 Jul; 41(4):263-266. PubMed ID: 32512984
[TBL] [Abstract][Full Text] [Related]
15. Comparison of diagnostic criteria for polycythaemia vera.
Turkington RC; Arnold EC; Percy MJ; Ranaghan LA; Cuthbert RJ; McMullin MF
Hematology; 2007 Apr; 12(2):123-30. PubMed ID: 17454193
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera.
Piris-Villaespesa M; Álvarez-Larrán A; Saez-Marín A; Nuñez-Torrón C; Muñoz-Martin G; Sánchez R; Del Castillo FJ; Villarrubia J; Lopez-Jimenez J; Martinez-Lopez J; Garcia-Gutierrez V
Sci Rep; 2021 Jan; 11(1):209. PubMed ID: 33420222
[TBL] [Abstract][Full Text] [Related]
17. A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.
Lussana F; Carobbio A; Randi ML; Elena C; Rumi E; Finazzi G; Bertozzi I; Pieri L; Ruggeri M; Palandri F; Polverelli N; Elli E; Tieghi A; Iurlo A; Ruella M; Cazzola M; Rambaldi A; Vannucchi AM; Barbui T
Br J Haematol; 2014 Nov; 167(4):541-6. PubMed ID: 25130523
[TBL] [Abstract][Full Text] [Related]
18. [A 53-year-old man with headache and concentration difficulties].
Vik A; Berntsen R; Isaksen V; Haug E; Hansen JB
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2647-9. PubMed ID: 16231451
[TBL] [Abstract][Full Text] [Related]
19. Hb Baden: a rare high affinity haemoglobin variant and its management.
Lee J; Harrison CN
J Clin Pathol; 2018 Jan; 71(1):79-80. PubMed ID: 28768701
[TBL] [Abstract][Full Text] [Related]
20. [From gene to disease; JAK2 and polycythaemia vera].
Koene HR; Biemond BJ; van der Schoot CE
Ned Tijdschr Geneeskd; 2007 Aug; 151(32):1784-7. PubMed ID: 17822250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
